SOPHIA GENETICS SA (SOPH) Stock News

USA - Nasdaq - NASDAQ:SOPH - CH1125843347 - Common Stock

4.85 USD

-0.17 (-3.39%)

Last: 12/5/2025, 8:00:02 PM

Technical Analysis

Fundamental Analysis

Analyst Ratings

Earnings Estimates

SOPH Latest News, Press Relases and Analysis

All

Press Releases

25 days ago - By: Sophia Genetics

SOPHiA GENETICS and Complete Genomics Integrate Sequencing and AI Analytics to Accelerate Adoption of Precision Medicine

25 days ago - By: Sophia Genetics

SOPHiA GENETICS and Element Biosciences Unite Sequencing Power and AI Analytics to Accelerate Global Research In Precision Medicine

a month ago - By: Benzinga - Mentions: LLY TREX NCLH HUBS ...

Zscaler To Rally More Than 9%? Here Are 10 Top Analyst Forecasts For Monday

a month ago - By: Benzinga - Mentions: KURA SEE HRMY FOLD ...

Earnings Scheduled For November 4, 2025

a month ago - By: Sophia Genetics

SOPHiA GENETICS Reports Third Quarter 2025 Results and Increases 2025 Revenue Guidance

a month ago - By: Myriad Genetics, Inc. - Mentions: MYGN

Myriad Genetics Reports Third Quarter 2025 Financial Results; Reiterates 2025 Financial Guidance Following Continued Solid Execution

2 months ago - By: Sophia Genetics

SOPHiA GENETICS to Announce Financial Results for Third Quarter 2025 on November 4, 2025

2 months ago - By: Zacks Investment Research - Mentions: TXG TEM

Tempus AI Stock Before Q3 Earnings Release: To Buy or Not to Buy?

2 months ago - By: Sophia Genetics

A.D.A.M. Innovations und SOPHiA GENETICS kooperieren, um Flüssigbiopsie-Tests und Begleitdiagnostik für Präzisionsonkologie in Japan voranzutreiben

2 months ago - By: Sophia Genetics

A.D.A.M. Innovations et SOPHiA GENETICS s'associent pour faire progresser les tests de biopsie liquide et les diagnostics compagnons pour l'oncologie de précision au Japon

2 months ago - By: Sophia Genetics

A.D.A.M. Innovations en SOPHiA GENETICS werken samen om vloeibare biopsietests en begeleidende diagnostiek voor precisieloncologie te bevorderen in Japan

2 months ago - By: Sophia Genetics

A.D.A.M. Innovations and SOPHiA GENETICS partner to advance liquid biopsy testing and companion diagnostics for precision oncology in Japan

2 months ago - By: Sophia Genetics

SOPHiA GENETICS Launches AI-Powered Digital Twins to Enhance Intelligent Decision-Making in Oncology

2 months ago - By: Sophia Genetics - Mentions: MYGN

Myriad Genetics and SOPHiA GENETICS to Develop an Innovative Companion Diagnostic Offering in Liquid Biopsy

2 months ago - By: Myriad Genetics, Inc. - Mentions: MYGN

Myriad Genetics and SOPHiA GENETICS to Develop an Innovative Companion Diagnostic Offering in Liquid Biopsy

3 months ago - By: Sophia Genetics - Mentions: AZN

SOPHiA GENETICS Expands Collaboration with AstraZeneca to Enhance Detection of Breast and Prostate Cancer

3 months ago - By: Sophia Genetics

SOPHiA GENETICS en Jessa Ziekenhuis kondigen samenwerking aan op het gebied van precisieoncologie tijdens het European Congress of Pathology

3 months ago - By: Sophia Genetics

SOPHiA GENETICS und Jessa Ziekenhuis verkünden Partnerschaft im Bereich der Präzisionsonkologie auf dem Europäischen Kongress für Pathologie

3 months ago - By: Sophia Genetics

SOPHiA GENETICS et Jessa Ziekenhuis annoncent un partenariat en oncologie de précision au Congrès européen de pathologie

3 months ago - By: Sophia Genetics

SOPHiA GENETICS and Jessa Ziekenhuis Announce Precision Oncology Partnership from the European Congress of Pathology

4 months ago - By: Zacks Investment Research - Mentions: AZN ABBV TEM

Strategic Partnerships Power Tempus AI's Healthcare Expansion

4 months ago - By: Zacks Investment Research - Mentions: IRTC TEM

Tempus AI Stock Jumps Post Q2 as EBITDA Breakeven Nears: Buy or Hold?

4 months ago - By: Sophia Genetics

SOPHiA GENETICS Reports Second Quarter 2025 Results

4 months ago - By: Sophia Genetics - Mentions: AZN

SOPHiA GENETICS expands collaboration with AstraZeneca using AI to improve breast cancer patient outcomes

7 months ago - By: Zacks Investment Research - Mentions: AZN IRTC TEM

After 92% YTD Surge, Is Tempus AI a Buy on Trump's Executive Order?

7 months ago - By: Zacks Investment Research - Mentions: CTEV

SOPHiA GENETICS SA (SOPH) Reports Q1 Loss, Tops Revenue Estimates

7 months ago - By: Sophia Genetics

SOPHiA GENETICS Reports First Quarter 2025 Results

7 months ago - By: Zacks Investment Research - Mentions: TXG TEM

Tempus AI Stock Surges 43% in Q1: Buy Now or Wait for Earnings?

7 months ago - By: Sophia Genetics - Mentions: AZN

SOPHiA GENETICS Announces Expanded Collaboration with AstraZeneca to Accelerate Liquid Biopsy Testing Globally from AACR